Cost-Effectiveness Analysis of Vildagliptin vs. Glimepiride as Add-On to Metformin in the Management of Type 2 Diabetes Mellitus in Greece
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2101
https://www.valueinhealthjournal.com/article/S1098-3015(15)04177-7/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1518
First Page :
A608
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04177-7&doi=10.1016/j.jval.2015.09.2101